Table 1.

Patient demographics and SSN characteristics

Number of patients	36
Male: Female	5:31
Number of SSNs (benign: malignant)	108 (31:77)
Patients with ≥3 SSNs	23 (36)
Mean age at baseline	69 ± 8 years
Mean age at follow-up	73 ± 8 years
Mean time intervals between baseline and follow-up	55 ± 32 months
Average size of SSNs at baseline (benign: malignant)	13.2 ± 6 mm: 12.7 ± 7 mm
Average size of SSNs at follow-up (benign: malignant)	13.3 ± 6 mm: 21.3 ± 17 mm